Deepen your clinical expertise with accredited guidance on diagnosing, assessing, and managing type 2 diabetes.

This article reviews an updated expert consensus treatment algorithm for managing cancer-associated thrombosis, including how the Khorana risk assessment model informs risk stratification within the pathway. Cancer-associated thrombosis carries distinct management considerations compared with thrombosis unrelated to malignancy, including anticoagulant choice and duration. Healthcare professionals can use this summary to align treatment decisions with current expert recommendations.

This article summarizes Royal College of Obstetricians and Gynaecologists guidance on reducing venous thromboembolism risk during pregnancy and the puerperium, a period associated with physiologically elevated thrombosis risk. The guidance outlines a structured approach to risk assessment and thromboprophylaxis recommendations across the antenatal and postpartum periods. Healthcare professionals can use this summary to support consistent application of these recommendations in obstetric practice.

This article provides a clinical overview of diabetes, including its pathophysiology, common microvascular and macrovascular complications, and current guideline-based management approaches. Understanding the mechanisms behind complications supports more effective patient counseling on the importance of sustained glycemic control. Healthcare professionals can use this overview as a foundational reference alongside more specific clinical tools available on the platform.

Contact details for medical information requests, adverse event reporting, and Campus platform support inquiries.

Structured risk stratification before Ramadan helps healthcare professionals categorize patients with diabetes based on their individual risk of fasting-related complications. This process considers factors such as glycemic control, treatment regimen, prior fasting experience and comorbidities. Healthcare professionals can use the resulting risk category to guide individualized counseling on fasting safety and any necessary treatment adjustments.

Fasting during Ramadan presents specific challenges for patients with diabetes, including altered meal timing, hypoglycemia and hyperglycemia risk, and the need for medication adjustments. This article outlines clinical guidance for managing diabetes therapy safely throughout the fasting period. Healthcare professionals can use this guidance to support structured pre-fasting counseling and treatment adjustments for their patients.

This support program is designed for patients beginning treatment with a long-acting basal insulin for type 2 diabetes, offering structured guidance through the titration period. It covers injection technique, dose-adjustment principles and recognizing signs of hypoglycemia. Healthcare professionals can refer patients to reinforce confidence with self-injection and reduce early discontinuation.